Diabetic macular edema: a literature review

Abstract

Diabetic Macular Edema is a major cause of visual impairment in economically active population, being responsible for a significant impact in quality of life in the affected population, as well as high costs to the health care system. Over decades, some studies have compared treatments using Laser, Anti-VEGF and intravitreous corticosteroids, establishing protocols to reach effectives therapies. Thus, it is essential an entire understanding of available therapies to reach the goal of disease control, in an individual basis and in a collective health care system, as efficient as possible.

Effects of Intra-Vitreal Diclofenac in Refractory Diabetic Macular Edema

“…There are a few treatment modalities available for DME. 9 These include laser treatment, intravitreal antivascular endothelial growth factor (anti-VEGF), and corticosteroids in the form of injections or implants. In laser therapy, damaged areas of the retina are targeted and leaking blood vessels are sealed along with and prevention of neovascularization.…”